Source: Annual Congress 2011 - Epidemiology of lung cancer and screening



Rating:

Share or cite this content

Citations should be made in the following way:
A. Bugge, A. Naalsund, M. B. Lund (Oslo, Norway). Current screening programs for lung cancer – Are inclusion criteria too rigorous to identify asymptomatic patients?. Eur Respir J 2011; 38: Suppl. 55, 2743

Member's Comments

No comment yet.

Related content which might interest you: Assessment of German national lung cancer guideline quality indicators in routine practice – Does the new TNM-system make a difference? Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 Case-finding for COPD: Developing strategies to identify patients at risk populations Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Clinical trials in advanced stage lung cancer: A survey of patients‘ opinion about their treatment Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Eligibility for lung cancer screening in Australia and the effect on screening eligibility of using spirometry to identify COPD Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Rational monitoring of COPD: where do current clinical guidelines stand? Source: Eur Respir J 2007; 29: 1078-1081 Year: 2007 Structured follow-up of COPD patients according to guidelines in primary care – Using a web-based data capture tool Source: Annual Congress 2010 - From diagnosis to disease management in primary care Year: 2010 Postoperative predicting value of lung function in patients with lung cancer – Fortune-telling or reality? Evaluation after surgical treatment Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011 Detecting undiagnosed COPD: Using routine primary care data to select and validate candidate variables for COPD risk prediction Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013 Impact of community pharmacists‘ interventions on patients‘ asthma control and perception of therapy and disease: Results in patients with inadequate control at inclusion Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010 Early detection of undiagnosed COPD in general practice; the yield of population-based screening according to socioeconomic status Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines Source: Annual Congress 2010 - State of the art imaging Year: 2010 Validation of the COPD lung cancer screening score in a community based cohort of COPD patients Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Does routine use of EBUS-TBNA and EUS-FNA improve the accuracy of staging of non small cell lung cancer patients – A national tumor registry based study Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer Year: 2011 Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring? Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020 Year: 2020 Prescriptions for treatment in patients with PCD: does clinical routine match recommendations? Source: Virtual Congress 2020 – Worldwide respiratory disease across the full spectrum Year: 2020 We provided patients with patients oriented diagnosis and treatment advice from their lung assessments using an algorithm. It was feasible and in general well appreciated by our patients Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016 A follow-up study (MARKO) supports the need to change the diagnostic criteria for COPD Source: International Congress 2016 – New approaches and finding in smoking cessation Year: 2016 Novel survey tool used to assess priorities of lung cancer patients and carers Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Non-adherence to treatment decisions made at a lung cancer multi-disciplinary meetings – Causes and frequency Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 Patients referred to a lung cancer clinic – does a clinical assessment at the outset have an impact on the investigations requested? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008